Xcath Robotics reported ongoing momentum for its Iris robotic platform, positioning telesurgery as a near-term pathway for expanding stroke treatment beyond specialized centers. CEO Eduardo Fonseca argued that remote operations could become routine clinical care within a decade, reflecting how robotic-assisted systems are increasingly being evaluated for safety and feasibility. While the report is forward-looking, the company’s messaging focuses on operational scalability and clinical integration—two requirements for converting telesurgery from demonstration to standard-of-care workflows. For stroke care systems, the strategic question is how to standardize robotic delivery across hospitals while maintaining outcomes and minimizing added training burden for clinicians.